เข้าลงนามในสญัญาหลกัเก่ียวกับการเข้าท าธุรกรรม (Master Transaction Agreement) และ สญัญาระหว่างผู้ ถือหุ้น (Shareholders Agreement) และอนุมัติให้บริษัทย่อยเพิ่มทุนจดทะเบียนจากจ านวน 556,536,900 บาท เป็น
resolution to approve this transaction, the Company shall enter into the Memorandum of Understanding and the Joint Venture Agreement with MERCURIA. The transaction shall be completed upon the conditions
the Company NYKT LRT Ms. Pimkarn Leungsuwan - General features of the transaction The Shareholders’ Agreement between the Company and NYK Group which is LRT’s major shareholder, dated 30 March 2012
signing of the share purchase agreement and execution of the transaction to be completed within 2nd quarter of 2023. Classification: Internal FY22 MD&A Advanced Info Service Plc. 3 FY22 Financial Summary
Characteristics of the Transaction: The company will purchase 100% of the ordinary shares of Modern Pharma Company Limited in accordance to the agreement in the Share Purchase Agreement. Prior to proceeding with
“Share Purchase Agreement”) collectively the “Shares Purchase Transaction”. (2) The tender offer for the remaining 451,889,002 shares in GLOW (equivalent to 30.89 percent of the total issued shares in GLOW
“Share Purchase Agreement”) collectively the “Shares Purchase Transaction”. (2) The tender offer for the remaining 451,889,002 shares in GLOW (equivalent to 30.89 percent of the total issued shares in GLOW
Developments B.V. (the “Seller”) on 20 June 2018 (the “Share Purchase Agreement”) collectively the “Shares Purchase Transaction”. (2) The tender offer for the remaining 451,889,002 shares in GLOW (equivalent to
the Transaction, the Company will execute a Share Subscription Agreement with conditions precedent and Loan Agreement with conditions precedent in respect of the Transaction (collectively, the
Company will execute a Share Subscription Agreement with conditions precedent and Loan Agreement with conditions precedent in respect of the Transaction (collectively, the “Agreements”) with SGAH. The